Financhill
Sell
37

ICUI Quote, Financials, Valuation and Earnings

Last price:
$142.70
Seasonality move :
0.78%
Day range:
$135.12 - $144.92
52-week range:
$100.69 - $196.26
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.46x
P/B ratio:
1.78x
Volume:
467.2K
Avg. volume:
316.1K
1-year change:
42.02%
Market cap:
$3.5B
Revenue:
$2.4B
EPS (TTM):
-$4.83

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
ICUI
ICU Medical
$574.2M $1.28 1.32% 316.67% $186.40
ABT
Abbott Laboratories
$10.4B $1.07 6.07% 68.64% $140.22
MASI
Masimo
$367.8M $1.21 -25.72% 321.55% $182.07
MMSI
Merit Medical Systems
$352.6M $0.75 10.03% 39.23% $107.00
PEN
Penumbra
$315.7M $0.67 9.31% 138.24% $318.59
RGEN
Repligen
$163.8M $0.35 9.93% 286.84% $183.13
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
ICUI
ICU Medical
$142.87 $186.40 $3.5B -- $0.00 0% 1.46x
ABT
Abbott Laboratories
$134.00 $140.22 $233.1B 17.38x $0.59 1.7% 5.53x
MASI
Masimo
$153.58 $182.07 $8.3B 116.80x $0.00 0% 4.22x
MMSI
Merit Medical Systems
$96.09 $107.00 $5.7B 47.10x $0.00 0% 4.16x
PEN
Penumbra
$288.73 $318.59 $11.2B 272.39x $0.00 0% 9.20x
RGEN
Repligen
$127.85 $183.13 $7.2B 633.44x $0.00 0% 11.06x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
ICUI
ICU Medical
44.61% 1.698 41.61% 0.92x
ABT
Abbott Laboratories
21.34% 0.621 6.18% 1.27x
MASI
Masimo
40.75% 1.411 7.21% 0.87x
MMSI
Merit Medical Systems
33.84% 1.291 11.7% 3.11x
PEN
Penumbra
-- 0.305 -- 3.45x
RGEN
Repligen
21.06% 1.369 7.41% 5.56x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
ICUI
ICU Medical
$227.3M $46.1M -3.22% -5.75% 5.46% $13.6M
ABT
Abbott Laboratories
$5.9B $1.7B 23.5% 31.31% 18.43% $933M
MASI
Masimo
$234M $80.7M -24.62% -39.91% 20.75% $27M
MMSI
Merit Medical Systems
$172M $42.1M 5.84% 9.19% 12.53% $19.1M
PEN
Penumbra
$215.9M $40.4M 3.62% 3.62% 13.63% $35.5M
RGEN
Repligen
$90.8M $6.6M -0.91% -1.16% 7.8% $10.6M

ICU Medical vs. Competitors

  • Which has Higher Returns ICUI or ABT?

    Abbott Laboratories has a net margin of -3.78% compared to ICU Medical's net margin of 12.79%. ICU Medical's return on equity of -5.75% beat Abbott Laboratories's return on equity of 31.31%.

    Company Gross Margin Earnings Per Share Invested Capital
    ICUI
    ICU Medical
    36.08% -$0.97 $3.5B
    ABT
    Abbott Laboratories
    56.86% $0.76 $62.3B
  • What do Analysts Say About ICUI or ABT?

    ICU Medical has a consensus price target of $186.40, signalling upside risk potential of 30.47%. On the other hand Abbott Laboratories has an analysts' consensus of $140.22 which suggests that it could grow by 4.64%. Given that ICU Medical has higher upside potential than Abbott Laboratories, analysts believe ICU Medical is more attractive than Abbott Laboratories.

    Company Buy Ratings Hold Ratings Sell Ratings
    ICUI
    ICU Medical
    3 1 0
    ABT
    Abbott Laboratories
    12 9 0
  • Is ICUI or ABT More Risky?

    ICU Medical has a beta of 0.870, which suggesting that the stock is 12.976% less volatile than S&P 500. In comparison Abbott Laboratories has a beta of 0.742, suggesting its less volatile than the S&P 500 by 25.819%.

  • Which is a Better Dividend Stock ICUI or ABT?

    ICU Medical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Abbott Laboratories offers a yield of 1.7% to investors and pays a quarterly dividend of $0.59 per share. ICU Medical pays -- of its earnings as a dividend. Abbott Laboratories pays out 28.62% of its earnings as a dividend. Abbott Laboratories's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios ICUI or ABT?

    ICU Medical quarterly revenues are $629.8M, which are smaller than Abbott Laboratories quarterly revenues of $10.4B. ICU Medical's net income of -$23.8M is lower than Abbott Laboratories's net income of $1.3B. Notably, ICU Medical's price-to-earnings ratio is -- while Abbott Laboratories's PE ratio is 17.38x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ICU Medical is 1.46x versus 5.53x for Abbott Laboratories. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ICUI
    ICU Medical
    1.46x -- $629.8M -$23.8M
    ABT
    Abbott Laboratories
    5.53x 17.38x $10.4B $1.3B
  • Which has Higher Returns ICUI or MASI?

    Masimo has a net margin of -3.78% compared to ICU Medical's net margin of -45.89%. ICU Medical's return on equity of -5.75% beat Masimo's return on equity of -39.91%.

    Company Gross Margin Earnings Per Share Invested Capital
    ICUI
    ICU Medical
    36.08% -$0.97 $3.5B
    MASI
    Masimo
    62.9% -$3.17 $1.6B
  • What do Analysts Say About ICUI or MASI?

    ICU Medical has a consensus price target of $186.40, signalling upside risk potential of 30.47%. On the other hand Masimo has an analysts' consensus of $182.07 which suggests that it could grow by 18.55%. Given that ICU Medical has higher upside potential than Masimo, analysts believe ICU Medical is more attractive than Masimo.

    Company Buy Ratings Hold Ratings Sell Ratings
    ICUI
    ICU Medical
    3 1 0
    MASI
    Masimo
    4 3 0
  • Is ICUI or MASI More Risky?

    ICU Medical has a beta of 0.870, which suggesting that the stock is 12.976% less volatile than S&P 500. In comparison Masimo has a beta of 1.229, suggesting its more volatile than the S&P 500 by 22.855%.

  • Which is a Better Dividend Stock ICUI or MASI?

    ICU Medical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Masimo offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. ICU Medical pays -- of its earnings as a dividend. Masimo pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ICUI or MASI?

    ICU Medical quarterly revenues are $629.8M, which are larger than Masimo quarterly revenues of $372M. ICU Medical's net income of -$23.8M is higher than Masimo's net income of -$170.7M. Notably, ICU Medical's price-to-earnings ratio is -- while Masimo's PE ratio is 116.80x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ICU Medical is 1.46x versus 4.22x for Masimo. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ICUI
    ICU Medical
    1.46x -- $629.8M -$23.8M
    MASI
    Masimo
    4.22x 116.80x $372M -$170.7M
  • Which has Higher Returns ICUI or MMSI?

    Merit Medical Systems has a net margin of -3.78% compared to ICU Medical's net margin of 8.48%. ICU Medical's return on equity of -5.75% beat Merit Medical Systems's return on equity of 9.19%.

    Company Gross Margin Earnings Per Share Invested Capital
    ICUI
    ICU Medical
    36.08% -$0.97 $3.5B
    MMSI
    Merit Medical Systems
    48.41% $0.49 $2.2B
  • What do Analysts Say About ICUI or MMSI?

    ICU Medical has a consensus price target of $186.40, signalling upside risk potential of 30.47%. On the other hand Merit Medical Systems has an analysts' consensus of $107.00 which suggests that it could grow by 11.35%. Given that ICU Medical has higher upside potential than Merit Medical Systems, analysts believe ICU Medical is more attractive than Merit Medical Systems.

    Company Buy Ratings Hold Ratings Sell Ratings
    ICUI
    ICU Medical
    3 1 0
    MMSI
    Merit Medical Systems
    4 1 0
  • Is ICUI or MMSI More Risky?

    ICU Medical has a beta of 0.870, which suggesting that the stock is 12.976% less volatile than S&P 500. In comparison Merit Medical Systems has a beta of 0.696, suggesting its less volatile than the S&P 500 by 30.439%.

  • Which is a Better Dividend Stock ICUI or MMSI?

    ICU Medical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Merit Medical Systems offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. ICU Medical pays -- of its earnings as a dividend. Merit Medical Systems pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ICUI or MMSI?

    ICU Medical quarterly revenues are $629.8M, which are larger than Merit Medical Systems quarterly revenues of $355.4M. ICU Medical's net income of -$23.8M is lower than Merit Medical Systems's net income of $30.1M. Notably, ICU Medical's price-to-earnings ratio is -- while Merit Medical Systems's PE ratio is 47.10x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ICU Medical is 1.46x versus 4.16x for Merit Medical Systems. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ICUI
    ICU Medical
    1.46x -- $629.8M -$23.8M
    MMSI
    Merit Medical Systems
    4.16x 47.10x $355.4M $30.1M
  • Which has Higher Returns ICUI or PEN?

    Penumbra has a net margin of -3.78% compared to ICU Medical's net margin of 12.1%. ICU Medical's return on equity of -5.75% beat Penumbra's return on equity of 3.62%.

    Company Gross Margin Earnings Per Share Invested Capital
    ICUI
    ICU Medical
    36.08% -$0.97 $3.5B
    PEN
    Penumbra
    66.6% $1.00 $1.2B
  • What do Analysts Say About ICUI or PEN?

    ICU Medical has a consensus price target of $186.40, signalling upside risk potential of 30.47%. On the other hand Penumbra has an analysts' consensus of $318.59 which suggests that it could grow by 10.34%. Given that ICU Medical has higher upside potential than Penumbra, analysts believe ICU Medical is more attractive than Penumbra.

    Company Buy Ratings Hold Ratings Sell Ratings
    ICUI
    ICU Medical
    3 1 0
    PEN
    Penumbra
    13 4 0
  • Is ICUI or PEN More Risky?

    ICU Medical has a beta of 0.870, which suggesting that the stock is 12.976% less volatile than S&P 500. In comparison Penumbra has a beta of 0.528, suggesting its less volatile than the S&P 500 by 47.181%.

  • Which is a Better Dividend Stock ICUI or PEN?

    ICU Medical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Penumbra offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. ICU Medical pays -- of its earnings as a dividend. Penumbra pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ICUI or PEN?

    ICU Medical quarterly revenues are $629.8M, which are larger than Penumbra quarterly revenues of $324.1M. ICU Medical's net income of -$23.8M is lower than Penumbra's net income of $39.2M. Notably, ICU Medical's price-to-earnings ratio is -- while Penumbra's PE ratio is 272.39x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ICU Medical is 1.46x versus 9.20x for Penumbra. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ICUI
    ICU Medical
    1.46x -- $629.8M -$23.8M
    PEN
    Penumbra
    9.20x 272.39x $324.1M $39.2M
  • Which has Higher Returns ICUI or RGEN?

    Repligen has a net margin of -3.78% compared to ICU Medical's net margin of 3.45%. ICU Medical's return on equity of -5.75% beat Repligen's return on equity of -1.16%.

    Company Gross Margin Earnings Per Share Invested Capital
    ICUI
    ICU Medical
    36.08% -$0.97 $3.5B
    RGEN
    Repligen
    53.65% $0.10 $2.5B
  • What do Analysts Say About ICUI or RGEN?

    ICU Medical has a consensus price target of $186.40, signalling upside risk potential of 30.47%. On the other hand Repligen has an analysts' consensus of $183.13 which suggests that it could grow by 43.23%. Given that Repligen has higher upside potential than ICU Medical, analysts believe Repligen is more attractive than ICU Medical.

    Company Buy Ratings Hold Ratings Sell Ratings
    ICUI
    ICU Medical
    3 1 0
    RGEN
    Repligen
    10 5 0
  • Is ICUI or RGEN More Risky?

    ICU Medical has a beta of 0.870, which suggesting that the stock is 12.976% less volatile than S&P 500. In comparison Repligen has a beta of 1.207, suggesting its more volatile than the S&P 500 by 20.699%.

  • Which is a Better Dividend Stock ICUI or RGEN?

    ICU Medical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Repligen offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. ICU Medical pays -- of its earnings as a dividend. Repligen pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ICUI or RGEN?

    ICU Medical quarterly revenues are $629.8M, which are larger than Repligen quarterly revenues of $169.2M. ICU Medical's net income of -$23.8M is lower than Repligen's net income of $5.8M. Notably, ICU Medical's price-to-earnings ratio is -- while Repligen's PE ratio is 633.44x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ICU Medical is 1.46x versus 11.06x for Repligen. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ICUI
    ICU Medical
    1.46x -- $629.8M -$23.8M
    RGEN
    Repligen
    11.06x 633.44x $169.2M $5.8M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

5 Investors to Follow Other Than Warren Buffett
5 Investors to Follow Other Than Warren Buffett

There is no doubt that Warren Buffett is one of…

Is BYD a Threat To Tesla Shareholders?
Is BYD a Threat To Tesla Shareholders?

BYD (OTC:BYDDY) has rocketed to the top of China’s booming…

CVX Vs XOM Stock, Which Energy Play Is Best?
CVX Vs XOM Stock, Which Energy Play Is Best?

Chevron (NYSE:CVX) and Exxon Mobil (NYSE:XOM) are two of the…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Buy
63
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Buy
99
DAVE alert for May 9

Dave [DAVE] is up 3.22% over the past day.

Buy
52
QDEL alert for May 9

QuidelOrtho [QDEL] is up 0.25% over the past day.

Buy
61
TPC alert for May 9

Tutor Perini [TPC] is up 3.58% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock